Transplant Diagnostics Leader Position One Lambda as a trusted, end-to-end provider of HLA typing and antibody detection assays within the transplant diagnostics market, leveraging its Thermo Fisher backing to pursue larger lab networks and hospital systems seeking standardized, high-quality transplant solutions.

Integrated Lab Tech Target opportunities around labs seeking integrated workflows by highlighting compatibility with Google Drive, OpenStack, Microsoft Azure Machine Learning and other techStack tools to streamline data management, analytics, and reporting for transplant patient monitoring.

Growth through Partnerships Leverage recent Thermo Fisher initiatives and strategic collaborations to propose co-developed or bundled solutions for transplant centers, including new instrumentation, assays, and services that complement existing platforms and expand share of wallet.

Mid Market Focus Capitalize on the company’s mid-size profile (51-200 employees) to tailor scalable, cost-effective solutions for medium-sized transplant laboratories and regional centers looking to upgrade capabilities without the scale of larger CROs, while aligning with Thermo Fisher’s broader ecosystem.

Innovation Pipeline Highlight ongoing product launches and enhancements such as expanded HLA coverage and advanced antibody assessment tools, presenting a roadmap of future capabilities to drive upsell and long-term contracts with labs aiming to stay at the forefront of transplant diagnostics.